Single-Use Devices: Why Reuse Is Prohibited Under MDR Article 17
Published 28 March 2026 · 8 min read
The Quiet Problem on Every Ward
Nobody writes it in a policy document. Nobody puts it in an email. But in hospitals under resource pressure — and which hospital isn't? — single-use devices are sometimes reused. A tourniquet marked for single use gets wiped down and reused on the next patient. A disposable surgical instrument gets sterilised and put back on the tray. Staff know it's wrong. They do it anyway because the alternative is not having the device at all.
Under the MDR, this practice is not just against hospital policy — it is a regulatory offence with serious patient safety implications.
What MDR Article 17 Says
MDR Article 17 addresses the reprocessing of single-use devices. The default position is clear: single-use devices are not to be reprocessed. The label says “single use” — that means one patient, one use, then disposal.
However, Article 17(2) includes an opt-in mechanism: EU Member States may allow reprocessing of certain single-use devices, provided they adopt national legislation that meets specific requirements — including requiring the reprocessor to take on the full obligations of a manufacturer.
Ireland has NOT opted into Article 17(2).
This means reprocessing of single-use medical devices is prohibited in Ireland. There is no legal pathway to reuse a device labelled for single use in an Irish hospital, regardless of the sterilisation method used.
Why the Label Matters
When a manufacturer labels a device as “single use”, they are making a regulatory declaration. It means:
- The device has been validated for one use only — the materials, coatings, and structural integrity are guaranteed for that single use cycle
- Sterilisation compatibility has only been validated for the manufacturer's original sterilisation process — not for hospital reprocessing
- The biocompatibility of materials may change after reprocessing — cleaning agents, heat, or radiation can alter surface properties
- Traceability breaks down — the UDI system assumes a single-use lifecycle. Reprocessing creates an untracked device
In short: the manufacturer has no data on what happens to the device after reprocessing. Nobody does. The hospital is putting a device of unknown performance characteristics into a patient.
The Real Risks
Reuse of single-use devices creates three categories of risk:
🦠 Infection Risk
Devices with internal lumens, crevices, or porous surfaces cannot be reliably cleaned and sterilised using standard hospital decontamination equipment. Biofilm formation is a particular concern in devices with narrow channels.
⚙️ Device Failure
Mechanical properties degrade. Cutting edges dull. Plastic components become brittle. Seals fail. A reprocessed device may look the same but perform differently — potentially during a critical procedure.
📋 Liability and Traceability
If a reprocessed device causes harm, the manufacturer's liability is voided — the device was used outside its intended purpose. The hospital (and potentially the individual who authorised reuse) assumes full liability.
What to Do Instead
Resource constraints are real. But the solution is not to reuse devices labelled for single use. Practical alternatives:
- Challenge the “single use” label at procurement stage: Some devices are labelled single-use by manufacturers to avoid validation costs, not because they genuinely cannot be reprocessed. Work with your clinical engineering team to identify where reusable alternatives exist.
- Negotiate with suppliers: Volume pricing, consignment stock, and longer contract terms can reduce per-unit costs
- Escalate stock shortages formally: If you are running out of a single-use device, report it through your hospital's supply chain escalation process — do not improvise
- Audit usage patterns: Are devices being opened unnecessarily? Are unused devices from opened packs being discarded?
Related Training
These modules cover device lifecycle management and compliance obligations: